Melt extrusion: from process to drug delivery technology

被引:501
作者
Breitenbach, J [1 ]
机构
[1] Soliqs Abbott GmbH & Co KG, D-67061 Ludwigshafen, Germany
关键词
melt extrusion; solid dispersion; solid molecular dispersion; extruder; bioavailability; solubility;
D O I
10.1016/S0939-6411(02)00061-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Starting from the plastic industry, today melt extrusion has found its place in the array of pharmaceutical manufacturing operations. This article reviews the process technology with regard to the set up and specific elements of the extruder as well as its application. Melt extrusion processes are currently applied in the pharmaceutical field for the manufacture of a variety of dosage forms and formulations such as granules, pellets, tablets, suppositories, implants, stents, transdermal systems and ophthalmic inserts. As a specific area the manufacture of solid dispersions, in particular, solid molecular dispersions using the melt extrusion process is reviewed. Melt extrusion is considered to be an efficient technology in this field with particular advantages over solvent processes like co-precipitation. Potential drawbacks like the influence of heat stress and shear forces on the drug active have been overcome in a number of examples with drugs of different chemical structure. Examples of suitable excipients and recent findings like self-emulsifying preparations are presented. The article concludes with a number of published examples of melt extrudates applying the principle of solid molecular dispersions. Improved bioavailability was achieved again demonstrating the value of the technology as a drug delivery tool. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:107 / 117
页数:11
相关论文
共 97 条
[1]  
Abd A., 1998, J DRUG RES EGYPT, V22, P15
[2]   Hot melt extrusion of acrylic films [J].
AitkenNichol, C ;
Zhang, F ;
McGinity, JW .
PHARMACEUTICAL RESEARCH, 1996, 13 (05) :804-808
[3]  
ANSCHEL J, 1976, THEORY PRACTICE IND, P234
[4]  
Baert L., 1997, Eur. Pat, Patent No. [872, 233, 872233, 0872233]
[5]  
BAERT L, 1996, Patent No. 0904060
[6]   Evaluation of soluble bioadhesive ophthalmic drug inserts (BODI®) for prolonged release of gentamicin:: Lachrymal pharmacokinetics and ocular tolerance [J].
Baeyens, V ;
Kaltsatos, V ;
Boisrame, B ;
Fathi, M ;
Gurny, R .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 1998, 14 (03) :263-272
[7]  
BARSHALOM D, 1988, Patent No. 0406315
[8]  
BAUER KH, 1993, PHARMAZEUTISCHE TECH, P292
[9]  
BERNDL G, 1998, AM ASS PHARM SCI ANN, P296
[10]  
BLOCH DW, 1987, PHARM ACTA HELV, V62, P23